Raloxifene and risk for stroke based on the framingham stroke risk score.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  American Journal of Medicine

• Publication date

  2009-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.amjmed.2009.01.033PMID 19540454
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of Raloxifene on Stroke and Venous Thromboembolism According to Subgroups in Postmenopausal Women at Increased Risk of Coronary Heart Disease

  2009cited by this paper
• Reduced incidence of invasive breast cancer with raloxifene among women at increased coronary risk.

  2008cited by this paper
• Statin therapy in stroke prevention: a meta-analysis involving 121,000 patients.

  2008cited by this paper
• Prediction of first coronary events with the Framingham score: a systematic review.

  2007cited by this paper
• Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, P

  2006cited by this paper
• Adult Weight Change and Risk of Postmenopausal Breast Cancer

  2006cited by this paper
• How Do American Stroke Risk Functions Perform in a Western European Population?

  2004cited by this paper
• Continued Breast Cancer Risk Reduction in Postmenopausal Women Treated with Raloxifene: 4-Year Results from the MORE Trial

  2004cited by this paper
• Breast cancer risk prediction with a log-incidence model: evaluation of accuracy.

  2003cited by this paper
• Commentary: How to derive causes from correlations in educational studies.

  2003cited by this paper
• Application of Framingham risk estimates to ethnic minorities in United Kingdom and implications for primary prevention of heart disease in general practice: cross sectional population based study

  2002cited by this paper
• Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial.

  2002cited by this paper
• Raloxifene and Cardiovascular Events in Osteoporotic Postmenopausal Women: Four-Year Results From the MORE (Multiple Outcomes of Raloxifene Evaluation) Randomized Trial

  2002cited by this paper
• Design and methods of the Raloxifene Use for The Heart (RUTH) study.

  2001cited by this paper
• Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.

  1999cited by this paper
• The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation.

  1999cited by this paper
• Survival and recurrence after first cerebral infarction

  1998cited by this paper
• Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study.

  1994cited by this paper
• Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community

  1994cited by this paper
• Stroke recurrence within 2 years after ischemic infarction.

  1991cited by this paper
• Probability of stroke: a risk profile from the Framingham Study.

  1991cited by this paper

• The 2024 UK clinical guideline for the prevention and treatment of osteoporosis

  2025cites this paper
• Pharmacological treatment of osteoporosis and prevention of fractures: recommendations for clinical practice

  2024cites this paper
• Current Treatment for Glucocorticoid-Induced Osteoporosis: Beyond Bisphosphonates

  2024cites this paper
• Oral Therapeutics Post Menopausal Osteoporosis

  2023cites this paper
• Effect of Isoflavones on Blood Lipid Alterations in Postmenopausal Females: A Systematic Review and Meta-Analysis of Randomized Trials

  2023cites this paper
• UK clinical guideline for the prevention and treatment of osteoporosis

  2022cites this paper
• Estrogen and estrogen analogs for prevention and treatment of osteoporosis

  2021cites this paper
• Menopausale Hormontherapie (MHT) bei internistischen Erkrankungen

  2020cites this paper
• An Elderly Health Monitoring System Using Machine Learning and In-Depth Analysis Techniques on the NIH Stroke Scale

  2020cites this paper
• Long-Term Drug Therapy and Drug Holidays for Osteoporosis Fracture Prevention: A Systematic Review

  2019cites this paper
• Menopausale Hormontherapie (MHT) bei internistischen Erkrankungen

  2019cites this paper
• Menopausale Hormontherapie (MHT) bei internistischen Erkrankungen

  2019cites this paper
• Orthoses for Osteoporosis

  2019cites this paper
• Long-Term Drug Therapy and Drug Discontinuations and Holidays for Osteoporosis Fracture Prevention

  2019cites this paper
• Deciphering the complex relationship between menopause and heart disease: 25 years and counting.

  2018cites this paper
• Cause or prevention of breast cancer with estrogens: analysis from tumor biologic data, growth kinetic model and Women’s Health Initiative study

  2018cites this paper
• Menopausale Hormontherapie (MHT) bei internistischen Erkrankungen

  2018cites this paper
• Estrogen Signaling as a Therapeutic Target in Neurodevelopmental Disorders

  2017cites this paper
• Selective Estrogen Receptor Modulators – an Update (Joint Statement by the German Society for Gynecological Endocrinology and Reproductive Medicine [DGGEF] and the German Professional Association of Gynecologists [BVF])

  2016cites this paper
• Effect of Adjunctive Raloxifene Therapy on Severity of Refractory Schizophrenia in Women: A Randomized Clinical Trial.

  2016cites this paper
• Menopausale Hormontherapie bei internistischen Erkrankungen

  2016cites this paper
• Menopausale Hormontherapie bei internistischen Erkrankungen

  2016cites this paper
• The effects of tamoxifen on spatial and nonspatial learning and memory impairments induced by scopolamine and the brain tissues oxidative damage in ovariectomized rats

  2015cites this paper
• Up-Date of the Consensus Statement of the Spanish Society f Rheumatology on Osteoporosis

  2015cites this paper
• Frakturprävention bei der älteren Frau

  2015cites this paper
• Raloxifene for women with Alzheimer disease

  2015cites this paper
• Selektive Östrogenrezeptormodulatoren (SERM)

  2015cites this paper
• Menopausale Hormontherapie (MHT) bei internistischen Erkrankungen

  2014cites this paper
• The effects of tamoxifen on learning, memory and brain tissues oxidative damage in ovariectomized and naïve female rats

  2014cites this paper
• [Selective Estrogen Receptor Modulators (SERMs) for prevention and treatment of postmenopausal osteoporosis].

  2012cites this paper
• Hormone therapy and the risk of stroke: perspectives 10 years after the Women's Health Initiative trials

  2012cites this paper
• Guidelines for the preventive treatment of ischaemic stroke and TIA (I). Update on risk factors and life style

  2012cites this paper
• Safety of Raloxifene in Hemodialysis Patients

  2012cites this paper
• Raloxifene and tibolone in elderly women: a randomized, double-blind, double-dummy, placebo-controlled trial.

  2012cites this paper
• Recommendations for raloxifene use in daily clinical practice in the Swiss setting

  2012cites this paper
• Guidelines for the preventive treatment of ischaemic stroke and TIA (I). Update on risk factors and life style.

  2012cites this paper
• Raloxifene for the treatment of postmenopausal osteoporosis

  2012cites this paper
• Use of recombinant tissue plasminogen activator in cancer patients with acute stroke

  2012cites this paper
• Hypocalcemia induced by raloxifene.

  2012cites this paper
• Vertebral Fracture Initiative Part I Overview of osteoporosis : Epidemiology and clinical management Authored by :

  2011cites this paper
• Actualización 2011 del consenso Sociedad Española de Reumatología de osteoporosis

  2011cites this paper
• Selective estrogen receptor modulators as brain therapeutic agents.

  2011cites this paper
• Actualización 2011 del consenso Sociedad Española de Reumatología de osteoporosis

  2011cites this paper
• Stroke in relation to use of raloxifene and other drugs against osteoporosis

  2011cites this paper
• Effects of toremifene and anastrozole on serum lipids and bone metabolism in postmenopausal females with estrogen receptor–positive breast cancer: the results of a 2-year multicenter open randomized study

  2011cites this paper
• Risque thromboembolique et prise en charge du cancer du sein

  2011cites this paper
• Postmenopausal hormone therapy: an Endocrine Society scientific statement.

  2010cites this paper
• Effect of Raloxifene on all-cause mortality.

  2010cites this paper
• Future Research Needs To Reduce the Risk of Primary Breast Cancer in Women

  2010cites this paper
• Another selective estrogen-receptor modulator for osteoporosis.

  2010cites this paper
• An evaluation of the NICE guidance for the prevention of osteoporotic fragility fractures in postmenopausal women

  2010cites this paper
• Drugs for the treatment of menopausal symptoms

  2010cites this paper
• Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society

  2010cites this paper
• The complex mutual connection between stroke and bone health.

  2010cites this paper
• NAMS continuing medical education activity Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society

  2010cites this paper
• Raloxifeen en de kans op een CVA

  2009cites this paper
• Nams Continuing Medical Education Activity Management of Osteoporosis in Postmenopausal Women: 2010 Position Statement of the North American Menopause Society Continuing Medical Education Management of Osteoporosis in Postmenopausal Women: 2010 Position Statement of the North American Menopause Soci

  year unknowncites this paper